ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1622

Cognitive Impairments in SLE Negatively Related to Participation and Quality of Life: A Systematic Review

Sofia Alfred1, Lina Khoja 1, Melanie Anderson 2, Zahi Touma 3 and Lisa Engel 4, 1University of Toronto, Toronto, Canada, 2University Health Network, Toronto, Canada, 3University Health Network, University of Toronto, Toronto, Canada, 4University of Manitoba, Winnipeg, MB, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: cognitive dysfunction and quality of life, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: SLE – Clinical Poster II: Comorbidities

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease affecting multiple organ systems. Approximately 33 to 43% of individuals with SLE experience cognitive impairments (CI) such as declines in attention/concentration, verbal fluency, visuo-spatial constructions, memory, processing speed and/or executive functions. Patients report significant effects of CI on Health Related Quality of Life (HRQoL), health status, and social participation roles. However, the quantitative data regarding the relationship of CI on these outcomes has not been synthesized.  The objective of this review is to critically appraise and synthesize literature on the relationship of CI on HRQoL, health status, and social participation roles in individuals with SLE.

Methods: Six electronic databases were searched using a wide search strategy and the support of a librarian. Two reviewers (SA, LK) independently completed all phases of the review (title/abstract screening, full-article selection, quality rating, extraction), and a third reviewer resolved disagreement (LE). Forward and backward citation searches of included articles were completed to ensure relevant articles were identified. Fourteen articles were selected for this review.

Results: Five thousand six hundred fifty- two titles were identified and screened. Fourteen articles were included in the data extraction process. Twelve of the fourteen articles found the presence of CI negatively correlated with individuals’ HRQoL and social participation roles such as employment status, academic performance and valued life activities (Figure 1). The most common cognitive domains assessed in these studies were memory, attention, language and executive function.  The two articles that did not find a relationship had a small sample size and unclear methodology. There was heterogeneity of measures used between studies: eight articles used different cognitive batteries, two articles used a self- report cognitive measure, and the remaining four articles used a brief cognitive screening measure to assess cognition. Three different HRQoL measures were used in the four articles examining HRQoL; all articles examining social role participation used different measures to assess social role participation. Studies were unable to be pooled for meta-analysis secondary to the heterogeneity across measures used.

Conclusion: Cognitive impairments are negatively related to HRQoL and social role participation in SLE patients. Healthcare professionals need to be aware of this relationship so that they are addressed in clinical practice. Further research is needed across different SLE patients using standardized metrics to enable pooling of data. Also, research examining a broader set of social participation roles, such as leisure, family and community roles, would provide more understanding of the effects of CI in SLE patients. Future research focusing on creating evidence-based treatment plans targeting CI, life roles participation, and/or HRQoL is needed.


Disclosure: S. Alfred, None; L. Khoja, None; M. Anderson, None; Z. Touma, None; L. Engel, None.

To cite this abstract in AMA style:

Alfred S, Khoja L, Anderson M, Touma Z, Engel L. Cognitive Impairments in SLE Negatively Related to Participation and Quality of Life: A Systematic Review [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/cognitive-impairments-in-sle-negatively-related-to-participation-and-quality-of-life-a-systematic-review/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cognitive-impairments-in-sle-negatively-related-to-participation-and-quality-of-life-a-systematic-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology